ClearPoint Neuro, Inc.
CLPT
$9.42
-$0.09-0.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.78% | 12.83% | 19.68% | 23.22% | 31.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.78% | 12.83% | 19.68% | 23.22% | 31.04% |
| Cost of Revenue | 16.39% | 10.17% | 17.98% | 11.43% | 18.63% |
| Gross Profit | 18.67% | 14.57% | 20.82% | 32.08% | 40.46% |
| SG&A Expenses | 17.74% | 17.07% | 18.61% | 15.01% | 8.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.06% | 15.95% | 20.63% | 14.45% | 10.18% |
| Operating Income | -13.33% | -21.01% | -22.08% | -3.49% | 12.08% |
| Income Before Tax | -34.83% | -27.72% | -23.65% | -0.82% | 14.43% |
| Income Tax Expenses | 358.33% | -56.82% | -16.67% | 0.00% | -- |
| Earnings from Continuing Operations | -35.03% | -27.51% | -23.58% | -0.81% | 14.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.03% | -27.51% | -23.58% | -0.81% | 14.37% |
| EBIT | -13.33% | -21.01% | -22.08% | -3.49% | 12.08% |
| EBITDA | -14.54% | -22.76% | -22.05% | -3.12% | 14.05% |
| EPS Basic | -28.93% | -19.54% | -13.21% | 9.51% | 22.16% |
| Normalized Basic EPS | -19.79% | -19.72% | -13.28% | 9.48% | 22.21% |
| EPS Diluted | -28.93% | -19.54% | -13.21% | 9.51% | 22.16% |
| Normalized Diluted EPS | -19.79% | -19.72% | -13.28% | 9.48% | 22.21% |
| Average Basic Shares Outstanding | 4.76% | 6.52% | 8.79% | 11.16% | 9.84% |
| Average Diluted Shares Outstanding | 4.76% | 6.52% | 8.79% | 11.16% | 9.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |